Enfinity Releases White Paper on U.S. PV Market in 2011

The report titled, "The U.S. PV Market in 2011", produced by Enfinity Solar in collaboration with GTM Research indicates that the US solar market in spite of holding fewer than 6% of the total global solar installations in 2010 will remain the center of the worldwide solar PV industry in 2011.

The research after examining the important market drivers of the solar PV industry of the USA indicates that the US solar markets will achieve vital growth in the year 2011.

The white paper released by Enfinity distinguishes three important elements that will help the USA with long-term and sustained solar PV market development. It mentions that the United States is blessed with abundant solar PV resources with its southwestern regions providing the highest level of solar exposure and its northeastern states though provide lesser exposure, provides more than or equal to that of Germany. As the second element, it mentions the vast availability of land resources in the country especially the large sized open lands in the western states to sustain large- sized solar PV installations. Lastly, the report compares the high level of electric power consumption of the country with Germany and Spain and mentions that the solar installations in the country have nearly doubled from 435 MW in 2009 to 820 MW in 2010 maintaining a steady level of growth.

Rafael Dobrzynski, CEO of Enfinity in the America, said that his company being dynamic in both European and US markets has always received questions about the potential of the US markets, increase in demand and the true position about the feed-in-tariff program prevailing in the country. He said that the white paper answers most of the key issues and offers important ideas with details of data.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.